Riskpilot← Back to searchSign inGet full accessCervello Øst ApS
APSActiveCVR 42364282Langebjerg 1Physiotherapy activities · NACE 8695Est. 202147 employeeswww.cervello.dk
Revenue 2024
DKK 15,1M
-21% vs 2023
EBITDA margin
18.9%
+18% vs 2023
Equity ratio
48.6%
Financial strength
Net profit 2024
DKK 2,2M
+60% vs 2023
| Revenue | DKK 15,1M | -21% |
| EBITDA | DKK 2,9M | +18% |
| Net profit | DKK 2,2M | +60% |
| Total assets | DKK 13M | +34% |
| Equity | DKK 6,3M | +103% |
| Employees | 47 | — |
Legal name
Cervello Øst ApS
CVR number
42364282
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
3. maj 2021
Share capital
DKK 40.000
Employees
47 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede
bestyrelse.
Company purpose
Selskabets formål er at drive aktiviteter vedrørende hjerneskade / Neuro-rehabilitering samt efter direktionens skøn hermed beslægtet virksomhed.
Address
Langebjerg 1
Phone
+4570602608
Website
www.cervello.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 16.674 | 22.660 | 19.155 | 15.117 |
| Staff expenses | -16.109 | -20.066 | -16.731 | -12.265 |
| EBITDA | 565 | 2.593 | 2.424 | 2.853 |
| Depreciation & amort. | -252 | -547 | -547 | -494 |
| EBIT | 313 | 2.046 | 1.877 | 2.359 |
| Net financials | -68 | -119 | -123 | 445 |
| Profit before tax | 245 | 1.926 | 1.753 | 2.803 |
| Tax | 54 | 424 | 386 | 617 |
| Net profit | 191 | 1.503 | 1.368 | 2.187 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 14.207 | 8.992 | 9.658 | 12.952 |
| Equity | 231 | 1.734 | 3.101 | 6.291 |
| Long-term debt | 3.159 | 3.226 | 3.211 | 3.371 |
| Short-term debt | 10.771 | 4.019 | 3.346 | 3.078 |
| Total debt | 13.930 | 7.245 | 6.557 | 6.449 |
EBITDA margin
18.9%
This company
15.8%
Market median
+20% vs market
20212024
Equity ratio
48.6%
This company
38.2%
Market median
+27% vs market
20212024
Return on equity
34.8%
This company
18.4%
Market median
+89% vs market
20212024
Net profit margin
14.5%
This company
8.1%
Market median
+79% vs market
20212024
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
20212024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-05-03 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HH Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2026 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2026 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cervello A/S | Company | 100.0% | 100.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Valby Familieholding Aps
Cervello Øst ApS Board members of Cervello Øst ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helene Hoffmann | Chief Executive Officer | 0 companies |
| Christopher Moyell Juul | Board of Directors | 0 companies |
| Karin Garre | Board of Directors | 0 companies |
| Jeanette Skjeldborg Johannsen | Board of Directors | 0 companies |
| Jørgen Thomsen | Chairman | 0 companies |
| Hans Hedegaard | Board of Directors | 0 companies |